Literature DB >> 3028550

The effects of N-(cyclopropylmethyl)-19-isopentylnororvinol (M320), a potent agonist at kappa- and mu-opiate receptors, on urine excretion of rats.

J M Abrahams, A L Boura, R G Evans, C I Johnston, J E Olley.   

Abstract

The effects of N-(cyclopropylmethyl)-19-isopentylnororvinol hydrochloride (M320) on urine excretion by rats were investigated. Further studies, using rabbit isolated vas deferens, investigated its interactions with kappa-opiate receptors. The output of urine for a 2 h period after M320, administered subcutaneously to normally hydrated Long Evans rats, showed a bell-shaped dose-response relationship, the maximum effect occurring after 10 micrograms kg-1. Urinary retention contributed to but did not fully account for the weaker diuresis after high doses. Attenuation of the ascending portion of the dose-response curve to M320 occurred after 1 and 10 mg kg-1 but not 0.1 mg kg-1 of naltrexone intraperitoneally. M320 in low doses (3-10 micrograms kg-1) caused a small but significant increase in sodium excretion. M320 (30 micrograms kg-1) reduced both sodium and potassium excretion. M320 (10 micrograms kg-1 s.c.) did not increase the volume of urine voided in 2 h by Brattleboro rats showing diabetes insipidus, even when urine excretion was reduced to normal by 1 week of vasopressin replacement. The volume of urine voided in 4 h by Brattleboro rats was progressively reduced to zero by M320 (10-100 micrograms kg-1 s.c.). Urinary retention contributed to but did not account for this reduction. Plasma levels of immunoreactive arginine vasopressin (ir-AVP) were reduced in both normal and dehydrated Long Evans rats after doses greater than 1 microgram kg-1 M320 s.c. In vitro, M320 caused persistent inhibition of twitches of the electrically stimulated rabbit vas deferens (IC50 1.7 nM). 8 These data suggest that M320 has potent opioid agonist activity at K-receptors and at higher concentrations stimulates mu- receptors. In the rat, its activity on K-receptors is associated with diuresis and suppression of plasma vasopressin levels. The antidiuresis seen after high doses may be due to its activity on mu-receptors, possibly at a central site.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028550      PMCID: PMC1917223          DOI: 10.1111/j.1476-5381.1986.tb11180.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  The pharmacology of N-(cyclopropylmethyl)-19-isopentylnororvinol hydrochloride. A potent and long lasting central depressant.

Authors:  A L Boura; A E Fitzgerald
Journal:  Br J Pharmacol Chemother       Date:  1966-02

2.  Antidiuretic effect of morphine and vasopressin in morphine tolerant and non-tolerant rats, differential effects on urine composition.

Authors:  F Huidobro; J Huidobro-Toro
Journal:  Eur J Pharmacol       Date:  1979-10-26       Impact factor: 4.432

3.  Rabbit vas deferens: a specific bioassay for opioid kappa-receptor agonists.

Authors:  T Oka; K Negishi; M Suda; T Matsumiya; T Inazu; M Ueki
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

4.  Bremazocine: a potent, long-acting opiate kappa-agonist.

Authors:  D Römer; H Büscher; R C Hill; R Maurer; T J Petcher; H B Welle; H C Bakel; A M Akkerman
Journal:  Life Sci       Date:  1980-09-15       Impact factor: 5.037

5.  Contribution of vasopressin to the maintenance of blood pressure during dehydration.

Authors:  R L Woods; C I Johnston
Journal:  Am J Physiol       Date:  1983-11

6.  A kappa opioid effect: increased urination in the rat.

Authors:  J D Leander
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

7.  Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine.

Authors:  G R Slizgi; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1982-03       Impact factor: 4.030

8.  Antidiuretic effect of beta-endorphin and morphine in Brattleboro rats: development of tolerance and physical dependence after chronic morphine treatment.

Authors:  J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

9.  Antidiuretic effect of acute morphine administration in the conscious rat.

Authors:  N Wilson; J Ngsee
Journal:  Can J Physiol Pharmacol       Date:  1982-02       Impact factor: 2.273

10.  Further study of kappa opioids on increased urination.

Authors:  J D Leander
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

View more
  3 in total

1.  Actions of tramadol on micturition in awake, freely moving rats.

Authors:  Raj Kumar Pandita; Rikard Pehrson; Thomas Christoph; Elmar Friderichs; Karl-Erik Andersson
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

2.  Studies of the effects of subacute treatment with N-(cyclopropylmethyl)-19-isopentylnororvinol (M320) on timing of parturition in the rat.

Authors:  R G Evans; G E Rice; J E Olley
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

3.  Chronic recurrent dehydration associated with periodic water intake exacerbates hypertension and promotes renal damage in male spontaneously hypertensive rats.

Authors:  Lucinda M Hilliard; Katrina M Mirabito Colafella; Louise L Bulmer; Victor G Puelles; Reetu R Singh; Connie P C Ow; Tracey Gaspari; Grant R Drummond; Roger G Evans; Antony Vinh; Kate M Denton
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.